Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Jun 5, 2024
- Accession no.
- 0001447362-24-000102
- Filed
- Jun 5, 2024
- Trade date
- Jun 3, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 14 non-derivative transactions. Open-market sales total $148.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | Common Stock | SSaleDisposed | −2,328 | $23.39F2 | −$54,451.92 | 57,933 | Direct | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −1,192 | $23.39F2 | −$27,880.88 | 82,502 | Indirect | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −1,192 | $23.39F2 | −$27,880.88 | 71,399 | Indirect | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −380 | $23.39F2 | −$8,888.2 | 8,533 | Indirect | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −380 | $23.39F2 | −$8,888.2 | 8,531 | Indirect | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −380 | $23.39F2 | −$8,888.2 | 8,531 | Indirect | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −380 | $23.39F2 | −$8,888.2 | 8,531 | Indirect | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −40 | $23.98F9 | −$959.2 | 57,893 | Direct | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −20 | $23.98F9 | −$479.6 | 82,482 | Indirect | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −20 | $23.98F9 | −$479.6 | 71,379 | Indirect | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −6 | $23.98F9 | −$143.88 | 8,527 | Indirect | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −6 | $23.98F9 | −$143.88 | 8,525 | Indirect | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −6 | $23.98F9 | −$143.88 | 8,525 | Indirect | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −6 | $23.98F9 | −$143.88 | 8,525 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $22.960 to $23.940, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $23.965 to $23.980, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.